This is a relevant question in the context of ccRCC, because p53 is rarely mutated but is maintained in an inactive state via poorly characterized mechanisms in this tumor, and its stabilization leads to cellular senescence (Amendolare et al, 2022; Xie et al, 2021). Here, TP53 is linked to nonpapillary renal cell carcinoma.